Skip to content

HIV Screening in the Emergency Department Setting

HIV Screening in the Emergency Department Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00667186
Enrollment
9572
Registered
2008-04-25
Start date
2008-01-31
Completion date
2010-12-31
Last updated
2013-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

HIV, Prevention, Public Health, Screening

Brief summary

Late diagnosis of HIV infection is believed to be responsible for high rates of HIV transmission. The purpose of this study is to determine whether targeted screening versus routine screening will identify a greater number of HIV infected participants. This study will also compare the costs of the resources used for targeted screening versus routine screening.

Detailed description

Novel strategies are needed to reduce HIV transmission, particularly among individuals who are unaware of their HIV status. Emergency departments (EDs) routinely receive individuals in a medical setting where an opportunity exists to screen them for HIV. The purposes of this study are to determine whether the proportion of tested participants identified as HIV infected by targeted screening exceeds routine screening and to determine whether the program resources used per infected patient identified are lower for targeted screening than for routine screening. Participants will be recruited from the University of Cincinnati Emergency Medicine Clinical Trials Center. The existing ED-based clinical HIV counseling and testing program in a lower HIV prevalence area will randomly alternate between two strategies for offering testing to ED participants: 1) targeted screening based on self-reported HIV risk and 2) routine screening. Participants will be randomly assigned to the targeted or routine screening group based on their presence in the ED during randomized days and times. At study entry an interview, blood collection, and counseling will occur. Participants will be telephoned following their ED visit to be given their negative results. Participants with positive results will be asked to return to the ED for notification, counseling, and connections to subsequent care. Participants who are HIV infected will be transferred to the University of Cincinnati Infectious Disease Center for care.

Interventions

OTHERTargeted Screening

Selection method for screening is based on risk

Selection method for screening is not based on risk

Sponsors

Ohio Department of Health, City of Cincinnati Board of Health
CollaboratorUNKNOWN
National Institute of Allergy and Infectious Diseases (NIAID)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Adult participants presenting for care in the ED

Exclusion criteria

* Participants cognitively unable or unwilling to consent for voluntary HIV counseling and testing

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Tested Participants Newly Diagnosed as HIV Infected3 yearsPercentage of tested participants newly diagnosed as HIV infected

Secondary

MeasureTime frameDescription
Percentage Consenting to Testing3 yearsPercentage of those successfully offered testing who consent to testing

Countries

United States

Participant flow

Recruitment details

This study enrolled patients from January 2008 through December 2010. This study was conducted in the emergency department of a Midwestern, urban, teaching hospital with an annual ED census of over 90,000 patient encounters.

Pre-assignment details

Patients were ineligible if age was \<18 or \>64, they were known to be positive, or they had been previously approached for HIV testing in the ED that day. Post-exposure testing (e.g. occupational, assault, etc.) was not provided and persons for whom such testing was indicated were excluded.

Participants by arm

ArmCount
Routine Screening
Participants approached at ED for voluntary HIV counseling and testing regardless of established risk according to age criteria Participant Screening Selection Criteria : Selection method for screening will be either based on risk or not based on risk
4,692
Targeted Screening
Participants approached at ED for voluntary HIV counseling and testing based on risk for HIV Participant Screening Selection Criteria : Selection method for screening will be either based on risk or not based on risk
4,880
Total9,572

Baseline characteristics

CharacteristicRoutine ScreeningTargeted ScreeningTotal
Age Continuous39 years
STANDARD_DEVIATION 13
39 years
STANDARD_DEVIATION 13
39 years
STANDARD_DEVIATION 13
Region of Enrollment
United States
4,692 participants4,880 participants9572 participants
Sex: Female, Male
Female
2373 Participants2430 Participants4803 Participants
Sex: Female, Male
Male
2319 Participants2450 Participants4769 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 4,6920 / 4,880
serious
Total, serious adverse events
0 / 4,6920 / 4,880

Outcome results

Primary

Percentage of Tested Participants Newly Diagnosed as HIV Infected

Percentage of tested participants newly diagnosed as HIV infected

Time frame: 3 years

Population: participants analyzed is restricted to the participants that consented to testing

ArmMeasureValue (NUMBER)
Routine ScreeningPercentage of Tested Participants Newly Diagnosed as HIV Infected6 percentage of tested that are positive
Targeted ScreeningPercentage of Tested Participants Newly Diagnosed as HIV Infected3 percentage of tested that are positive
Secondary

Percentage Consenting to Testing

Percentage of those successfully offered testing who consent to testing

Time frame: 3 years

Population: the number consenting to testing divided by the number offered testing

ArmMeasureValue (NUMBER)
Routine ScreeningPercentage Consenting to Testing40.8 percentage of offered testing who consen
Targeted ScreeningPercentage Consenting to Testing47.4 percentage of offered testing who consen

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026